Karol Merrifield
Family · Fitzgerald, GANPI 1801554449
Payments from drug & device makers
Across 109 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$547
- Novo Nordisk$274
- AstraZeneca$257
- AbbVie$213
- Lilly USA, LLC$164
- Astellas Pharma US Inc$132
- plus $599 from 17 others
What the payments were for
- Food & beverage$2,09596%
- Education$924%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 26 | $547 |
| Novo Nordisk | 12 | $274 |
| AstraZeneca | 15 | $257 |
| AbbVie | 13 | $213 |
| Lilly USA, LLC | 9 | $164 |
| Astellas Pharma US Inc | 3 | $132 |
| Axsome Therapeutics, Inc. | 4 | $116 |
| Bayer | 4 | $82 |
| Ardelyx, Inc. | 2 | $57 |
| Dexcom, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $46 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $14 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$2,187 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 109 | $133,856 |
| MounjaroTirzepatide | 92 | $126,721 |
| EliquisApixaban | 131 | $94,149 |
| FarxigaDapagliflozin Propanediol | 88 | $78,485 |
| LinzessLinaclotide | 80 | $62,932 |
| JardianceEmpagliflozin | 47 | $44,630 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $40,970 |
| XareltoRivaroxaban | 52 | $40,462 |
| Tresiba Flextouch U-100Insulin Degludec | 56 | $37,473 |
| VraylarCariprazine Hcl | 20 | $30,466 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $23,715 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $20,558 |
| TrulicityDulaglutide | 12 | $17,981 |
| JanuviaSitagliptin Phosphate | 12 | $16,071 |
| MyrbetriqMirabegron | 14 | $7,590 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $164 | $144,702104 claims |
| Novo NordiskOzempic | $274 | $133,856109 claims |
| AbbVieLinzess, Vraylar | $213 | $93,398100 claims |
| AstraZenecaFarxiga, Symbicort | $257 | $82,404100 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $29 | $50,58259 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $547 | $47,00866 claims |
| Astellas Pharma US IncMyrbetriq | $132 | $7,59014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.
Other family in Fitzgerald
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.